Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




C-Reactive Protein Point-Of-Care Test Evaluated

By LabMedica International staff writers
Posted on 27 Aug 2019
C-reactive protein (CRP) is a key mediator of the acute-phase response, with blood levels of CRP increasing rapidly after an inflammatory stimulus. More...
Therefore, changes in serum levels of CRP are a clinically useful marker of infection, inflammation, and tissue injury.

CRP testing in the primary setting as in point-of-care (POC) can help reduce diagnostic uncertainty by differentiating between bacterial and viral infections and has been shown to be cost-effective for reducing inappropriate antibiotic prescriptions. However, despite the availability of POC devices, POC CRP testing has not yet been widely adopted in primary care clinics.

Clinical laboratory scientists at the Catharina Hospital and Technical University Eindhoven (Eindhoven, The Netherland) and their colleagues evaluated a POC CPR test at three sites and one reference laboratory. Within-run (repeatability), within-laboratory (intermediate precision), and between-laboratory precision (reproducibility) were assessed. Method comparison and matrix/lot-to-lot comparison studies were conducted using prospectively collected blood samples from 217 adults (apparently healthy or with clinically relevant conditions).

The investigators compared the analytical performance of the cobas b 101 POC system, which provides glycated hemoglobin (HbA1c) and lipid panel tests (measurement of cholesterol, triglyceride, and high-density lipoprotein; calculation of low-density lipoprotein) for managing diabetes and dyslipidemia at point-of-need. This method was compared with a reference test: CRPNX reagent on a Roche cobas c 501 module.

The scientists reported that clinically relevant CRP concentrations measured with the CRP Test showed good agreement with those measured by CRPNX reagent. Coefficients of variation (CV) for repeatability and intermediate precision ranged from 1.7%–4.0% and 1.9%–4.5%, respectively, for human serum pools containing CRP 4.7–350.7 mg/L; repeatability in clinical samples ranged from 1.6%–5.9% (3.3–360.3 mg/L). CVs for reproducibility ranged from 2.5%–4.0% (4.7–344.3 mg/L). CRP concentrations were comparable for capillary whole blood, serum, Li-heparin whole blood/plasma, K2 and K3 EDTA whole blood/plasma. The overall mean usability score was 4.18/5 and the error rate across 9,378 tests was 1.00%.

The authors concluded that their findings indicate that healthcare professionals can obtain precise and reproducible CRP values with the cobas POC CRP Test that show very good correlation with laboratory measurements. Importantly, operators considered the system convenient for use in the POC environment. The study was published in the September 2019 issue of the journal Clinical Biochemistry.

Related Links:
Catharina Hospital and Technical University Eindhoven


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.